ew SARS-CoV-2 detection system (COVID-19)

Not Applicable

• Conditions: COVID-19 patients; COVID-19; C000657245

• Registration Number: JPRN-jRCT1032200025
• Lead Sponsor: Watanabe Yoshiyuki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-05-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients with suspected new coronavirus infection (COVID-19)

Exclusion Criteria

1 Patients who did not get consent to participate in this study
2 Patients who could not collect the samples required for this study
3 Patients judged to be inappropriate by the doctor in charge and the attending physician

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate the positive match rate, negative match rate, and overall match rate of the test drug new corona gene detection reagent against the real-time RT-PCR method based on the National Institute of Infectious Diseases Pathogen Detection Manual 2019-nCoV .